Clinical Trial Update: Safety and Efficacy Study of Isolagen TherapyTM in Treatment of Interdental Papillary Insufficiency [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study of Isolagen Therapy in interdental papillary insufficiency has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interdental Papillary Insufficiency

Drugs mentioned

• Isolagen Therapy (autologous fibroblast therapy)

Snippet

Sponsor: Castle Creek Biosciences, LLC. | Conditions: Interdental Papillary Insufficiency | Phase 2 | Status: COMPLETED | Results posted: 2013-08-15